Key result
A 68-year-old patient with severe COVID-19 pneumonia complicated by pneumothorax died 33 days after admission, suggesting pneumothorax may be associated with acute decompensation and poor outcome.
Why the study?
Pneumothorax is an uncommon complication of COVID-19 pneumonia, and the association of the two conditions may serve as a prognosis indicator.
Case Report (n=1)
Pneumothorax in COVID-19 patients may be associated with an increased inflammatory response, acute decompensation, and poor outcomes.
Introduction: Coronavirus disease (COVID-19) is known as a highly infectious disease with several systemic complications and may lead to a severe acute lung injury. Pneumothorax is a potential though uncommon complication and the association of the two conditions may be a prognosis indicator. Case Report: We report the case of a pneumothorax complicating severe COVID-19 pneumonia in a 68-year-old patient who died 33 days after admission despite supportive measures. Conclusion: Our case highlights the increased inflammatory response as a potential underlying mechanism of pneumothorax in COVID-19 patients, which may be associated with acute decompensation and poor outcome.
No takes yet. Share an insight, caveat, or question.
Soumaya et al. (2021) conducted a case report in COVID-19 pneumonia (n=1). Pneumothorax was evaluated on Mortality. A 68-year-old patient with severe COVID-19 pneumonia complicated by pneumothorax died 33 days after admission, suggesting pneumothorax may be associated with acute decompensation and poor outcome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: